- Rating
- 2(+1)
- Confidence
- 3
- Informativeness
- 1
- Presentation
- 2
- Soundness
- 1
Read review
Paper summary
ReDiM decomposes RNA-to-protein prediction into a reference prediction and a low-dimensional residual correction, incorporating spatial RNA and RNA-derived metabolic network features. The problem is relevant, but the method primarily combines a frozen predictor, PCA, graph networks, and metabolic features. The experiments show some predictive gains, yet do not establish a compelling methodological contribution. In particular, the emphasis on spatial information, shared geometry, and biological interpretation exceeds what the current evidence supports.
Critical strengths
- Domain-level holdouts, training-domain PCA, and separate spatial graphs provide a reasonably credible evaluation framework.
- Direct prediction, full-dimensional residual, mean-correction, capacity-matched, and shuffled-FES controls support some predictive value. The authors also acknowledge several important limitations.
Critical weaknesses
-
The necessity of the core design remains unproven. The comparison between the frozen reference predictor and M1 simultaneously introduces a trained correction network, RNA inputs, and spatial neighborhoods. It therefore does not isolate the contribution of spatial context. Without a capacity-matched nonspatial correction model trained under the same supervision, the main gains could simply reflect an additional RNA prediction network. This omission substantially weakens the argument for the proposed spatial design.
-
The external comparisons do not yet establish a clear competitive advantage. STProtein, DGAT, and totalVI are relevant baselines, but their access to the paired reference data used by ReDiM is unclear. The Brain experiments also rely on region-matched reference data for the held-out target region. Consequently, their transfer setting is narrower than the phrase “held-out region” might suggest. Until reference-data access and output-scale transformations are documented, the rankings in Table 3 are insufficient to establish a clear methodological advantage.
-
The shared-geometry and attribution analyses lack convincing calibration. Predicted corrections are constrained by a fixed PCA decoder, so cross-domain subspace similarity cannot directly establish that the model learns meaningful shared residual structure. Unconstrained random subspaces do not adequately control for this architectural restriction. The directional-agreement metric in Figure S2 is also ambiguous. For example, ITGAX has two positive values but is labeled as having 1/3 agreement. Acknowledging these limitations does not substitute for validation. These analyses currently provide descriptions of model outputs rather than strong evidence for the representation or its biological interpretation.
-
The limited gains do not yet justify the additional pipeline. FES produces small, dataset-dependent RMSE improvements. On ALS, the full model increases RMSE from the reference predictor’s 0.307 to 0.332, despite improving correlation. The manuscript does not adequately establish the stability of these gains or report the actual costs of reference training and spFBA preprocessing. Given the additional paired-data requirements and processing stages, the practical value of this pipeline remains unclear.
Questions for authors
- How much benefit does the spatial branch retain against a capacity-matched nonspatial correction model trained under identical supervision?
- Does ReDiM retain its advantage when all methods receive the same paired reference data?
- Would random latent predictions passed through each fold’s fixed decoder produce comparable cross-domain subspace similarity?
- Could the authors provide domain-level paired differences, complete attribution definitions, reproducible FES configurations, and end-to-end computational costs to justify the additional complexity?
6 comments
W3 / Q3 — Decoder calibration and corrected FES attribution
W3 / Q3 — Decoder calibration and corrected FES attribution
Decoder calibration. We agree that predicted-subspace similarity alone cannot establish learned shared geometry when folds have related decoders and overlapping training domains. We therefore withdrew that interpretation and replaced the original Figure 2B comparison with a direct held-out correction-recovery test, calibrated using fold-specific Haar orientation randomizations with each fitted decoder held fixed. Predicted–observed correction-coordinate correlations were 0.421 for ALD, 0.361 for ALS, and 0.350 for Brain and exceeded the null in all nine held-out units (Figure 2B). After decoding into the common 31-protein space, recovery also exceeded the corresponding 95% null intervals in all nine units (Figure S1). We revised Section 4.1 and Appendix C to distinguish this evidence for correction predictability from the original cross-domain affinity interpretation.
Attribution definition and calibration. The ITGAX discrepancy required clarification and correction of the aggregation and agreement convention. The previous panel used a seed-42 rerun and compared donor signs with a pooled cross-donor direction, producing the ambiguous ITGAX 1/3 result. The corrected analysis first averages seeds 42–44 within each donor. Agreement is defined as the fraction of the three donor means sharing the majority nonzero sign; effects with absolute magnitude ≤10⁻⁸ are treated as zero and do not count toward agreement. ITGAX now shows 2/3 agreement; eight proteins show 3/3 (Figure S2). We replaced Figure S2 and specified the aggregation and agreement rules in Appendix C.2. We also expanded Section 4.5 with shuffled-control calibration: seven proteins show consistent signs in at least 8/9 donor-seed combinations with real FES, compared with none for shuffled FES, and mean pairwise donor-effect cosine similarity is 0.39 versus 0.04 (Figure 4). These comparisons calibrate the reproducibility of decoded model effects, not causal regulation.
W4 / Q4 — Practical value, robustness, FES configuration, and computational cost
W4 / Q4 — Practical value, robustness, FES configuration, and computational cost
The practical significance of ReDiM combines controlled predictive refinement with an inspectable representation of context-dependent RNA–protein correction. The reaction-annotated FES view is linked to decoded protein corrections, allowing its contribution to be tested at both protein and tissue levels. Its value should therefore be assessed through these capabilities as well as endpoint error.
The predictive trade-offs remain explicit. In ALS, M3 improved Spearman correlation from 0.286 to 0.318 but increased RMSE from 0.307 to 0.332 relative to the frozen reference (Table 2). To assess the consistency of the additional FES contribution, we added domain-level paired results, showing that M3 reduced RMSE relative to M1 in 6/9 domains (mean difference -0.0038; Table A7), and real FES outperformed the capacity-matched shuffled control in 7/9 domains (mean difference -0.0024; Table A8). Together with the capacity-matched RNA controls in Table A5, these comparisons argue against added parameter count alone as a sufficient explanation.
We also added a 16D/31D robustness comparison that separates endpoint performance from across-seed prediction variability (Figure S4), and a within-checkpoint FES-assignment permutation analysis for the sl5 ITGAX result. The observed discordance–benefit association (ρ=0.258) exceeded all 1,000 assignment permutations (empirical p=0.001; Figure S5). Thus, the interpretation analysis is supported by a test of assignment-specific predictive benefit, not only by visualization of model outputs. These additions are incorporated into Sections 4.1 and 4.6, Appendix C.2, and Figures S4–S5.
We also expanded Appendix B and Tables A3 and A11 to document the FES configuration and computational cost. The recorded configuration includes MAGIC, ENGRO2 gene–protein–reaction aggregation, FVA-constrained GLPK optimization, 20 Raspy CBS solutions per spot, section standardization, and fold-specific filtering and PCA. Across the 32 spatial samples used in this study (4 ALD, 12 ALS, and 16 Brain), recorded FES sampling and statistics aggregation required 42,533.34 seconds (11.81 hours) in total. FES was computed once per spatial sample and cached for reuse across correction-model runs. A representative ALD profile required approximately 21 seconds for reference-predictor fitting; the available ALS and Brain profiles included data loading and did not isolate fitting time. With prepared FES and spatial graphs, median M3 training times were 2.0, 10.2, and 13.4 seconds per fold and seed for ALD, ALS, and Brain, respectively, with at most 1.2 GB GPU memory. Cached inference required 0.006, 0.020, and 0.020 seconds per held-out unit, respectively. Because the FES timings were recovered from historical executions using heterogeneous sampling modes, they are reported as an aggregate one-time preprocessing cost rather than as a controlled cross-dataset benchmark. These measurements characterize stage-specific costs and do not constitute complete end-to-end deployment latency; accordingly, we do not claim an end-to-end efficiency advantage.
W1 / Q1 — Isolating the spatial contribution, W2 / Q2 — Equal paired-data access and Brain evaluation scope
We sincerely thank the reviewer for the careful reading and insightful feedback.
W1 / Q1 — Isolating the spatial contribution
The spatial branch supplies tissue-neighborhood context to ReDiM’s decodable correction representation, supporting protein prediction while allowing protein-specific correction patterns to be examined in their spatial biological context. The relevant question is whether this neighborhood context contributes beyond what a spot-level correction network can already learn.
To isolate this contribution, we added and trained nonspatial controls matched to M1 and M3 in inputs, supervision, data splits, seeds, and optimization settings. In these controls, inter-spot edges were replaced with self-loops (NS1 and NS3), retaining each spot’s own features while removing information exchange between neighboring spots.
M1 exceeded NS1 in mean protein-wise Spearman correlation by 0.021 in ALD, 0.041 in ALS, and 0.014 in Brain, corresponding to a domain-equal mean gain of 0.025, and in 26/27 domain-seed comparisons. M3 exceeded NS3 by a domain-equal mean of 0.020 in mean protein-wise Spearman correlation and in 8/9 held-out domains (Table A10). Thus, the rank-recovery benefit of neighborhood aggregation was observed both without FES (M1 versus NS1) and with FES (M3 versus NS3).
We have added these controls to Table A10 and incorporated the results into Section 4.2. These results support a specific role for the spatial branch: neighboring-spot context contributes to predicting relative protein abundance across spots, beyond the correction learned from spot-level inputs alone. This predictive contribution complements ReDiM’s decodable representation, through which the resulting protein-specific corrections can be examined spatially.
W2 / Q2 — Equal paired-data access and Brain evaluation scope
The comparison uses matched paired supervision. We agree, however, that the Brain setting evaluates correction transfer with anatomy-matched reference supervision, rather than transfer to unseen anatomy. ReDiM, STProtein, DGAT, and totalVI received the same paired reference observations and paired outer-training target observations, and were evaluated on the same held-out units and common 31-protein CLR evaluation panel. Held-out proteins were unavailable to every method during training, adaptation, checkpoint selection, and model selection (Tables 3 and A13). To make these supervision boundaries explicit, we expanded Table A1 with reference-cohort composition and paired-spot counts, added the method-access matrix in Table A13, and clarified the comparison in Section 4.3. The access matrix distinguishes paired training supervision from RNA-only query adaptation.
Table A1 reports the reference cohorts: 6,714 spots from two non-ALD liver sections; 72,953 spots from nine control cervical-spinal-cord sections; and four Brain anchors fitted using three nAD donors per region. Each evaluated Brain donor-region was excluded from reference fitting, correction training, graph construction, checkpoint selection, and model selection, while its anatomy was represented in the corresponding nAD reference for every method. For ReDiM, the held-out target was represented by a separate graph constructed from its RNA and spatial coordinates without protein labels. We clarified this evaluation scope in Section 3.1 and Appendix A and revised the Table 3 caption to identify the region-matched reference anchor.